跳至主要内容
临床试验/PACTR201510001274643
PACTR201510001274643招募中未知

Clinical effect of lowering heart rate in sepsis syndromes; comparing ivabradine 10 mg and 15 mg versus placebo.

anesthesia and ICU departement , faculty of medicine, Cairo univ0 个研究点目标入组 90 人开始时间: 2015年9月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 99 Year(s)(—)
性别
All

入选标准

  • severe sepsis, septic shock or Multiple organ dysfunction syndrome
  • -Sinus rhythm with heart rate ¿ 90bpm

排除标准

  • refusal by the patient or the responsible guardian
  • ¿Patients younger than 18 years of age
  • ¿Hypersensitivity to the active substance or any of the excipients
  • ¿Pregnancy, lactation
  • ¿Patients with a history of pre-existing chronic renal failure with a glomerular filtration rate <30ml/min
  • ¿Patients with malignant hyperthermia or burn patients
  • ¿Patients with acute rejection after organ transplantation
  • ¿Patients who have participated or participate in other studies within the last 3 months
  • ¿Other types of shock than septic or cardiogenic shock
  • ¿Patients with severe valvular heart disease
  • ¿Severe hepatic insufficiency
  • ¿Sick sinus syndrome
  • ¿pacemaker-dependency
  • ¿3rd degree AV block
  • ¿Use of potent cytochrome P450 3A4 inhibitors such as antifungals of the azole -type (ketoconazole, itraconazole), macrolide antibiotics (clarithromycin, erythromycin)

研究者

发起方
anesthesia and ICU departement , faculty of medicine, Cairo univ

相似试验